Last updated: 20 June 2019 at 2:55am EST

Keith Serzen Net Worth




The estimated Net Worth of Keith Serzen is at least $5.82 Million dollars as of 9 August 2007. Keith Serzen owns over 20,000 units of Resmed stock worth over $5,817,160 and over the last 21 years Keith sold RMD stock worth over $0.

Keith Serzen RMD stock SEC Form 4 insiders trading

Keith has made over 3 trades of the Resmed stock since 2006, according to the Form 4 filled with the SEC. Most recently Keith exercised 20,000 units of RMD stock worth $410,800 on 9 August 2007.

The largest trade Keith's ever made was exercising 25,000 units of Resmed stock on 7 June 2006 worth over $549,750. On average, Keith trades about 6,875 units every 54 days since 2004. As of 9 August 2007 Keith still owns at least 23,000 units of Resmed stock.

You can see the complete history of Keith Serzen stock trades at the bottom of the page.



What's Keith Serzen's mailing address?

Keith's mailing address filed with the SEC is 14040 DANIELSON STREET, , POWAY, CA, 92064.

Insiders trading at Resmed

Over the last 22 years, insiders at Resmed have traded over $250,830,262 worth of Resmed stock and bought 10,000 units worth $424,500 . The most active insiders traders include Peter C Farrell, Gary W Pace und David Pendarvis. On average, Resmed executives and independent directors trade stock every 7 days with the average trade being worth of $3,005,701. The most recent stock trade was executed by Brett Sandercock on 9 September 2024, trading 1,000 units of RMD stock currently worth $246,420.



What does Resmed do?

at resmed (nyse: rmd, asx: rmd) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. our cloud-connected medical devices transform care for people with sleep apnea, copd and other chronic diseases. our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. by enabling better care, we improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries.



Complete history of Keith Serzen stock trades at Resmed

Insider
Trans.
Transaktion
Gesamtpreis
Keith Serzen
Leiter des operativen Geschäfts
Optionausübung $410,800
9 Aug 2007
Keith Serzen
Leiter des operativen Geschäfts
Optionausübung $219,900
17 Nov 2006
Keith Serzen
Leiter des operativen Geschäfts
Optionausübung $549,750
7 Jun 2006


Resmed executives and stock owners

Resmed executives and other stock owners filed with the SEC include: